Identifying candidate biomarkers of effects of deoxynivalenol exposure using proteomics
✍ Scribed by André Nogueira da Costa; Renée Mijal; Jeff Keen; John Findlay; Christopher Wild
- Book ID
- 119380370
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 89 KB
- Volume
- 180
- Category
- Article
- ISSN
- 0378-4274
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
There is an urgent need for novel biomarkers that can be used to improve the diagnosis, predict the disease progression, improve our understanding of the pathology or serve as therapeutic targets for neurodegenerative diseases. Cerebrospinal fluid (CSF) is in direct contact with the CNS and reflects
## Abstract Although serum prostate specific antigen (PSA) is a well‐established diagnostic tool for prostate cancer (PCa) detection, the definitive diagnosis of PCa is based on the information contained in prostate needle biopsy (PNBX) specimens. To define the proteomic features of PNBX specimens